Dr. Ahrens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-1828Fax+1 319-356-7171
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Allergy and Immunology, 1977 - 1980
- SSM Health/Saint Louis University School of MedicineResidency, Pediatrics, 1974 - 1975
- SSM Health/Saint Louis University School of MedicineInternship, Internal Medicine, 1973 - 1974
- Medical College of WisconsinClass of 1973
Certifications & Licensure
- IA State Medical License 1977 - 2021
- AR State Medical License 1973 - 2019
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Clinical Trials
- OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis Start of enrollment: 2014 Jun 01
- Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation Start of enrollment: 2015 Nov 01
Publications & Presentations
PubMed
- 364 citationsEfficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D MutationJane C. Davies, Claire E. Wainwright, Gerard J. Canny, Mark A. Chilvers, Michelle S. Howenstine
American Journal of Respiratory and Critical Care Medicine. 2013-06-01 - 46 citationsRandomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.Richard B. Moss, Nicole Mayer-Hamblett, Jeffrey S. Wagener, Cori L. Daines, Kathryn A Hale
Pediatric Pulmonology. 2005-03-01 - 79 citationsIntestinal mast cell levels control severity of oral antigen-induced anaphylaxis in mice.Richard Ahrens, Heather Osterfeld, David Wu, Chun-Yu Chen, Muthuvel Arumugam
The American Journal of Pathology. 2012-04-01
Grant Support
- Ultrase MT20 For Correction Of Steatorrhea In Patients With Cystic FibrosisNational Center For Research Resources2007
- Tiotropium Bromide Administered VIA The Respimat Device In CF PatientsNational Center For Research Resources2007
- Genetic Modifiers Of Cystic Fibrosis: Sibling StudyNational Center For Research Resources2007
- Eurand Pancreatic Enzyme Product Microtabs In Pediatric CF PatientsNational Center For Research Resources2007
- Eruand Pancreatic Enzyme Product (PEP) In Patients With Cystic FibrosisNational Center For Research Resources2007
- Aztreonam Lysinate In CF Patients With Pulmonary Pneumonia AeruginosaNational Center For Research Resources2007
- Antimicrobial Therapy For New Onset Pseudomonas Aeruginosa Airway InfectionNational Center For Research Resources2006–2007
- Standard Versus Biofilm Susceptibility Testing In Cystic FibrosisNational Center For Research Resources2005–2007
- Multicenter Investigation Of Genetic Modifier In CF Lung Or Liver Disease StudyNational Center For Research Resources2005–2007
- Induced Sputum To Evaluate Anti-Inflammatory Agents In CF PatientsNational Center For Research Resources2006
- Oral Theraclec-Total In Cystic Fibrosis SubjectsNational Center For Research Resources2005
- Biil 284 Bs In Adult And Pediatric Cystic Fibrosis PatientsNational Center For Research Resources2005
- Oral Theraclec To Treat Cystic FibrosisNational Center For Research Resources2004
- Biil 284 Bs In Adult And Pediatric Cystic FibrosisNational Center For Research Resources2004
- Aztreonam For Inhalation In Subjects W/ Cystic FibrosisNational Center For Research Resources2004
- Trial Of Ib-367 In Adult Patients With Cystic FibrosisNational Center For Research Resources2000–2002
- Elastase In BAL Fluid W Tg-Haat Treated Cystic FibrosisNational Center For Research Resources2000–2002
- Oral Multidose CPX In Adult Patients W/ Cystic FibrosisNational Center For Research Resources1999–2002
- Phase I Trial Of CPX In Adults With Mild Cystic FibrosisNational Center For Research Resources1998–2000
- Albuterol By DRY Powder Inhaler &Pressurized Metered Dose Ventolin InhalerNational Center For Research Resources1998–2000
- Dose Response Curve For Beclomethasone Dipropionate In AsthmaNational Center For Research Resources1996–1997
- Bronchoprovocation With Histamine For Bioequivalence Determination Of AlbuterolNational Center For Research Resources1996–1997
- Clinical Parameters For Establishing Dose Response Curves For CorticosteroidsNational Center For Research Resources1996
- Glucocorticoids To Treat Bronchopulmonary DysplasiaNational Center For Research Resources1992–1996
- The Albuterol Dose-Fev1 Response Curve In Subjects With AsthmaNational Center For Research Resources1992–1993
- Pharmacokinetic Evaluation Of A Slow Release Theophylline Tablet In ChildrenNational Center For Research Resources1992–1993
- Comparison Of Beta-2 Agonists Using Bronchial Provocation With HistamineNational Center For Research Resources1992–1993
- Tolerance To Inhaled BETA2 AgonistsNational Center For Research Resources1992
- The Effect Of Inhaled Nedocromil On Airway Response To Inhaled AlbuterolNational Center For Research Resources1992
- Effects Of Nedocromil On Airway Response To Inhaled AlbuterolNational Center For Research Resources1992
- Effects Of Oral Azelastine On Airway Responisvieness To HistamineNational Center For Research Resources1990
- Effects Of Inhaled Fluticasone Proprionate Versus Placebo In Adult AsthmaticsNational Center For Research Resources1990
- Comparison Of Beta-2 Agonists Using Bronchial Provocation With Histamine (HumanNational Center For Research Resources1990
- Mechanism Of Histamine Induced BronchospasmNational Center For Research Resources1985
- Development Of Tolerance For MetaproterenolNational Center For Research Resources1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: